Insights

Targeted Oncology Validation INOVOTION offers in vivo chick embryo–based efficacy and early toxicity assays for anti-cancer treatments, enabling rapid Go/No Go decisions and multi-cancer screening. This can appeal to biotech and pharma teams seeking cost-effective target validation and early-stage screening to de-risk programs before large preclinical investments.

Cost-Effective Acceleration The core value proposition emphasizes saving time and money by accelerating drug discovery and reducing costs through early exclusion of low-value molecules. Sales conversations can frame INOVOTION as a budget-friendly way to improve R&D productivity and throughput for small to mid-size biotech firms and university collaborations.

Budget-Conscious Partners With revenue under $1M and a modest funding base, INOVOTION is well-positioned to partner with startups, academic spinouts, and contract research organizations seeking affordable, reliable in vivo evaluation services to complement internal pipelines without heavy capital commitments.

Strategic Alliances Recent leadership hires and active presence at industry events (AFFSSI Connexions, bio-europe Spring) indicate openness to collaborations and visibility in the life sciences community. Target partnerships with companies attending these events or hiring in R&D, business development, and collaborations could yield short-term deals.

Expansion Opportunities The platform supports multi-cancer screening and target validation, suggesting cross-industry appeal (biotech, academic labs, pharma). There is room to upsell by offering expanded assay panels, tiered pricing for high-volume clients, and co-development programs to scale usage as customer projects grow.

Similar companies to INOVOTION

INOVOTION Tech Stack

INOVOTION uses 8 technology products and services including iCIMS, WordPress, Shopify, and more. Explore INOVOTION's tech stack below.

INOVOTION's Email Address Formats

INOVOTION uses at least 2 email formats:
INOVOTION Email FormatsExamplePercentage
First.Last@inovotion.comJohn.Doe@inovotion.com
93%
F.Last@inovotion.comJ.Doe@inovotion.com
7%

Frequently Asked Questions

What is INOVOTION's official website and social media links?

Minus sign iconPlus sign icon
INOVOTION's official website is inovotion.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does INOVOTION generate?

Minus sign iconPlus sign icon
As of October 2026, INOVOTION's annual revenue is estimated to be <$1M.

What is INOVOTION's SIC code and NAICS code?

Minus sign iconPlus sign icon
INOVOTION's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does INOVOTION have currently?

Minus sign iconPlus sign icon
As of October 2026, INOVOTION has approximately 14 employees across 1 continents, including Europe. Key team members include Ceo: J. V., Chief Executive Officer: J. V. and Scientific Business Development Director: A. P. Explore INOVOTION's employee directory with LeadIQ.

What industry does INOVOTION belong to?

Minus sign iconPlus sign icon
INOVOTION operates in the Biotechnology Research industry.

What technology does INOVOTION use?

Minus sign iconPlus sign icon
INOVOTION's tech stack includes iCIMS, WordPress, Shopify, Microsoft 365, Linkedin Sign-in, Sendinblue, Piwik PRO Core and Apache.

What is INOVOTION's email format?

Minus sign iconPlus sign icon
INOVOTION's email format typically follows the pattern of First.Last@inovotion.com. Find more INOVOTION email formats with LeadIQ.

How much funding has INOVOTION raised to date?

Minus sign iconPlus sign icon
As of October 2026, INOVOTION has raised $53K in funding. The last funding round occurred on Jan 01, 2017 for $53K.

When was INOVOTION founded?

Minus sign iconPlus sign icon
INOVOTION was founded in 2014.
INOVOTION logo

INOVOTION

Biotechnology ResearchAuvergne-Rhône-Alpes, France11-50 Employees

INOVOTION is a biotechnology research company based in la Tronche, Auvergne-Rhône-Alpes, 38700 France, with a team of 11 to 50 employees. The company provides an in vivo assay platform dedicated to anti-cancer treatment evaluations and early toxicity studies, utilizing a chick embryo-based approach. The platform is described as fast, sensitive, reliable and affordable, aiming to accelerate drug discovery by enabling early screening before traditional preclinical stages and supporting rapid Go/No Go decisions across multiple cancer targets. INOVOTION's in vivo tests cover four main areas: efficacy assays, early toxicity assays, target validation in oncology, and multi-cancer screening. The company serves chemists and biologists from industry and academia to validate targets and develop treatments within budget, moving candidates through in vivo evaluation.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $53K

    INOVOTION has raised a total of $53K of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2017 in the amount of $53K as a Grant.

  • <$1M

    INOVOTION's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.